Skip to main content
. 2021 Aug 13;5(16):3066–3075. doi: 10.1182/bloodadvances.2020004055

Table 2.

PPV and NPV for all patients and those with anemia, neutropenia, and thrombocytopenia, also demonstrated for patients with bicytopenia and pancytopenia

MDS, n (%) No MDS, n (%) PPV, % [95% CI] NPV, % [95% CI]
Total (all patients) 502 (100) 502 (100) 88.4 [79.9, 93.6] 94.3 [93.4, 95.2]
Cytopenia: WHO *
 Anemia 454 (90.44) 354 (70.52) 85.0 [74.8, 91.6] 94.8 [93.8, 95.7]
 Neutropenia 178 (35.46) 66 (13.20) 73.4 [51.5, 87.8] 97.4 [95.9, 98.4]
 Thrombocytopenia 210 (41.83) 174 (34.66) 86.8 [67.9, 95.3] 93.2 [91.6, 94.5]
 Bicytopenia 184 (36.65) 112 (22.40) 82.2 [60.2, 93.5] 93.3 [91.5, 94.8]
 Pancytopenia 83 (16.53) 31 (6.20) 72.3 [40.4, 91.0] 98.2 [95.7, 99.2]
Severe cytopenia: IPSS
 Anemia 244 (48.61) 151 (30.08) 85.7 [69.4, 94.1] 95.7 [94.3, 96.8]
 Neutropenia 135 (26.89) 48 (9.60) 89.1 [54.0, 98.3] 97.6 [95.7, 98.6]
 Thrombocytopenia 124 (24.70) 103 (20.52) 90.0 [60.9, 96.3] 93.8 [91.7, 95.4]
 Bicytopenia 94 (18.73) 41 (8.20) 84.1 [48.7, 93.9] 96.9 [94.6, 98.2]
 Pancytopenia 25 (4.98) 9 (1.80) 57.5 [21.5, 79.8] 97.5 [90.8, 99.4]

IPSS, International Prognostic Scoring System; WHO, World Health Organization.

*

Cytopenia according to WHO criteria: anemia (hemoglobin: <12 g/dL, women; <13 g/dL, men), neutropenia (absolute neutrophil count, <1.8 × 109/L), and thrombocytopenia (platelets, <150 × 109/L).

Severe cytopenia, using IPSS criteria: anemia (hemoglobin, <10 g/dL), neutropenia (absolute neutrophil count, <1.5 × 109/L), and thrombocytopenia (platelets, <100 × 109/L).